Summit Therapeutics Inc. (SMMT) Deep Dive Video

Summary

Summit Therapeutics is a binary oncology bet: ivonescimab could disrupt Keytruda-sized markets, but failure to replicate China data globally could severely impair the stock.

View SMMT stock page · Read the SMMT research report

Loading the video player…